Plasma MMP-9 - a marker of carotid plaque instability

被引:67
作者
Loftus, IM [1 ]
Naylor, AR [1 ]
Bell, PRF [1 ]
Thompson, MM [1 ]
机构
[1] Univ Leicester, Dept Surg, Leicester LE1 7RH, Leics, England
关键词
MMP-9; gelatinases; plaque instability; embolisation; transcranial Doppler;
D O I
10.1053/ejvs.2000.1278
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: to investigate whether peripheral blood levels of matrix metalloproteinases (MMPs) or their inhibitors are altered in patients with particulate cerebral embolisation. Design: a prospective study. Materials and methods: using sandwich enzyme immunoassay, plasma levels of MMPs-1, -2, -3 and -9, plus TIMPs-1 and -2 were quantified in 70 consecutive patients undergoing carotid endarterectomy. Patients were monitored with transcranial Doppler (TCD) preoperatively and during the dissection phase of the operation to detect those with spontaneous particulate embolisation (n = 21). Results: the plasma level of MMP-9 was significantly higher in those patients with evidence of spontaneous embolisation compared to those without. There were no differences in other MMP levels, or plasma concentrations of TIMPs. Conclusions: plasma MMP-9 levels are elevated in patients with particulate cerebral embolisation, and this may represent a novel marker of atherosclerotic instability.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 27 条
  • [1] Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
    Anthony, DC
    Ferguson, B
    Matyzak, MK
    Miller, KM
    Esiri, MM
    Perry, VH
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) : 406 - 415
  • [2] Medial elastic structure alterations in atherosclerotic arteries in minipigs: Plaque proximity and arterial site specificity
    Augier, T
    Charpiot, P
    Chareyre, C
    Remusat, M
    Holland, PH
    Garcon, D
    [J]. MATRIX BIOLOGY, 1997, 15 (07) : 455 - 467
  • [3] Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications
    Basset, P
    Okada, A
    Chenard, MP
    Kannan, R
    Stoll, I
    Anglard, P
    Bellocq, JP
    Rio, MC
    [J]. MATRIX BIOLOGY, 1997, 15 (8-9) : 535 - 541
  • [4] THE NATURAL-HISTORY OF ASYMPTOMATIC CAROTID-ARTERY DISEASE
    BOCK, RW
    GRAYWEALE, AC
    MOCK, PA
    STATS, MA
    ROBINSON, DA
    IRWIG, L
    LUSBY, RJ
    PERLOFF, LJ
    GREENHALGH, RM
    [J]. JOURNAL OF VASCULAR SURGERY, 1993, 17 (01) : 160 - 171
  • [5] IDENTIFICATION OF 92-KD GELATINASE IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS - ASSOCIATION OF ACTIVE ENZYME-SYNTHESIS WITH UNSTABLE ANGINA
    BROWN, DL
    HIBBS, MS
    KEARNEY, M
    LOUSHIN, C
    ISNER, JM
    [J]. CIRCULATION, 1995, 91 (08) : 2125 - 2131
  • [6] Matrix metalloproteinase inhibitors in the treatment of cancer
    Brown, PD
    [J]. MEDICAL ONCOLOGY, 1997, 14 (01) : 1 - 10
  • [7] Atherosclerotic plaque rupture in symptomatic carotid artery stenosis
    Carr, S
    Farb, A
    Pearce, WH
    Virmani, R
    Yao, JST
    [J]. JOURNAL OF VASCULAR SURGERY, 1996, 23 (05) : 755 - 765
  • [8] Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases
    Cawson, T
    [J]. MOLECULAR MEDICINE TODAY, 1998, 4 (03): : 130 - 137
  • [9] Changing views of the role of matrix metalloproteinases in metastasis
    Chambers, AF
    Matrisian, LM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) : 1260 - 1270
  • [10] Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro
    Crowther, M
    Brindle, NPJ
    Sayers, R
    Bell, PRF
    Thompson, MM
    [J]. ABDOMINAL AORTIC ANEURYSM: GENETICS, PATHOPHYSIOLOGY, AND MOLECULAR BIOLOGY, 1996, 800 : 283 - 285